This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Isoprenaline

Authoring team

Isoprenaline has beta-1- and beta-2-adrenoceptor activity, and thus acts to markedly improve cardiac output. However, after some years of use of this drug there was a gradual increase in the number of sudden deaths after surgery, probably reflecting an increase in age of the population undergoing surgery. The older population has poorer coronary vessels and is thus unable to increase blood flow in vessels so much.

Increased heart rate and arterial pressure with isoprenaline reduces perfusion pressure and duration of diastole, and results in poor blood flow to myocardium with subsequent damage. Slowed conduction through ischaemic areas results in arrhythmias.

It is used in circulatory failure associated with bradycardia and in heart block, and also in situations where there is excessive vasoconstriction.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.